Top Markets
#1 DogBull DogBull +25.95%
#2 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#3 Siacoin Siacoin +17.80%
#4 Cash Cat Cash Cat +13.29%
#5 The Bitcoin Bull The Bitcoin Bull +10.51%
#6 Asteroid Shiba Asteroid Shiba +8.70%
#7 0G 0G +8.69%
#8 Akedo Akedo +7.86%
#9 The Black Bull The Black Bull +6.19%
#10 Seeker Seeker +6.12%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Novartis India Limited Novartis India Limited

Novartis India Limited

NOVARTIND
Rank in Stocks #14294
Novartis India Limited, an Indian healthcare enterprise, provides a diverse... Novartis India Limited, an Indian healthcare enterprise, provides a diverse range of pharmaceutical solutions. Its offerings include branded medications for conditions related to bone and pain management, calcium supplementation, women's health (gynecology), and neurological disorders. Furthermore, the company supplies generic drugs specifically for gynecological issues, anti-tuberculosis treatments, and anti-infective applications. Notable branded products within its portfolio comprise Tegrital and Exelon for central nervous system disorders, Voveran for pain and inflammation relief, and specialized transplantation/immunology drugs like Simulect, Certican, Myfortic, and Sandimmun Neoral. Established in 1947 and headquartered in Mumbai, India, Novartis India Limited operates as a subsidiary of Novartis AG.
Share Price
$17.15
Last synced: 2026-08-31
Market Cap
$423.01M
Change (1 day)
4.67%
Change (1 year)
112.68%
Country
IN
Trade Novartis India Limited (NOVARTIND)

Category

Healthcare
P/B ratio for Novartis India Limited (NOVARTIND)
P/B ratio as of 2026 TTM: 0
According to Novartis India Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Novartis India Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5.5207 -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH